Illustration of the Fitbone Transport and Lengthening System. Credit: Business Wire / Orthofix Medical Inc.

Orthofix Medical has secured the 510(k) clearance from the US Food and Drug Administration (FDA) for its Fitbone Transport and Lengthening System.

This medical device is designed to address large bone defects in the femur and tibia resulting from trauma, infection or malignant conditions, through a single surgical procedure.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Featuring a similar motorised technology used in the Fitbone TAA Intramedullary Lengthening System, the Fitbone system is implanted via a minimally invasive procedure and includes a motorised intramedullary nail, a receiver, and an external control set.

This allows patients to self-manage the bone distraction phase from the comfort of their home.

After treatment completion, the nail and receiver are surgically removed.

Orthofix president and CEO Massimo Calafiore said: “The Fitbone Transport and Lengthening System further demonstrates our commitment to expanding surgical options for hard-to-treat conditions, specifically within trauma, that can have a big impact on a patient’s quality of life.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are proud of this milestone achievement and our continued innovation and advancement of the Fitbone product family that has already transformed the lives of so many patients.”

The Fitbone Transport and Lengthening System is now available in the US on a limited market release basis.

Limb Restoration and Lengthening Program in New Haven, Connecticut director and orthopaedic surgeon Dr David Frumberg performed the first implantation of the Fitbone system in the US.

Frumberg said: “Patients with defects to the femur and tibia can be difficult to treat and often have undergone multiple prior surgeries.

“The Fitbone Transport and Lengthening System is a game-changing new option that enables bone to be transported across the defect, allowing very challenging problems to be treated without multiple follow-up surgeries.”

Last year, Orthofix Medical commercially introduced its WaveFormL lateral lumbar interbody system in the US.